356 related articles for article (PubMed ID: 10472531)
1. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
Schadewaldt P; Hammen HW; Ott AC; Wendel U
J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.
Schadewaldt P; Hammen HW; Dalle-Feste C; Wendel U
J Inherit Metab Dis; 1990; 13(2):137-50. PubMed ID: 2116545
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
4. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
5. Utilization of the L- and DL-isomers of alpha-keto-beta-methylvaleric acid by rats and comparative efficacy of the keto analogs of branched-chain amino acids provided as ornithine, lysine and histidine salts.
Funk MA; Lowry KR; Baker DH
J Nutr; 1987 Sep; 117(9):1550-5. PubMed ID: 3116181
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of branched-chain amino acids in maple syrup urine disease.
Schadewaldt P; Wendel U
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD.
S Sonnet D; N O'Leary M; A Gutierrez M; M Nguyen S; Mateen S; Hsu Y; P Mitchell K; J Lopez A; Vockley J; K Kennedy B; Ramanathan A
Sci Rep; 2016 Jul; 6():28775. PubMed ID: 27373929
[TBL] [Abstract][Full Text] [Related]
9. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
10. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
11. Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in plasma and dried blood samples using HPLC with fluorescence detection.
Kand'ár R; Záková P; Jirosová J; Sladká M
Clin Chem Lab Med; 2009; 47(5):565-72. PubMed ID: 19290779
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters.
Rabelo F; Lemos IDS; Dal Toé CP; Casagrande DD; Freitas MLS; Quadra MR; Lima IR; Generoso JS; Michels M; Silveira PCL; Pizzol FD; Streck EL
Metab Brain Dis; 2023 Jun; 38(5):1573-1579. PubMed ID: 36897514
[TBL] [Abstract][Full Text] [Related]
13. Metabolic flux analysis of branched-chain amino and keto acids (BCAA, BCKA) and β-hydroxy β-methylbutyric acid across multiple organs in the pig.
Ten Have GAM; Jansen L; Schooneman MG; Engelen MPKJ; Deutz NEP
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E629-E640. PubMed ID: 33522397
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
15. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
Schadewaldt P; Wendel U
Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
[TBL] [Abstract][Full Text] [Related]
16. Transamination and oxidative decarboxylation rates of branched-chain 2-oxo acids in cultured human skin fibroblasts.
Schadewaldt P; Radeck W; Hammen HW; Wendel U
Pediatr Res; 1988 Jan; 23(1):40-4. PubMed ID: 3340442
[TBL] [Abstract][Full Text] [Related]
17. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
18. Thiamine response in maple syrup urine disease.
Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
[TBL] [Abstract][Full Text] [Related]
19. Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.
Schadewaldt P; Dalle-Feste C; Langenbeck U; Wendel U
Pediatr Res; 1991 Nov; 30(5):430-4. PubMed ID: 1754297
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
